Cargando…
The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease accompanied with severe paralysis or even death, while the pathogenesis of ALS is still unclear and no effective therapy exists. The accumulating evidence has indicated the association between gut microbiota and various neurological...
Autores principales: | Zeng, Qianqian, Shen, Jie, Chen, Kangzhi, Zhou, Jinxia, Liao, Qiao, Lu, Ke, Yuan, Jiao, Bi, Fangfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398913/ https://www.ncbi.nlm.nih.gov/pubmed/32747678 http://dx.doi.org/10.1038/s41598-020-69845-8 |
Ejemplares similares
-
Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes
por: Zhou, Jinxia, et al.
Publicado: (2023) -
Altered RNA metabolism and amyotrophic lateral sclerosis
por: Verma, Ashok
Publicado: (2011) -
A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men
por: Martin, Sarah, et al.
Publicado: (2022) -
Altered Metabolic Profiles of the Plasma of Patients with Amyotrophic Lateral Sclerosis
por: Chang, Kuo-Hsuan, et al.
Publicado: (2021) -
Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis
por: Li, Jin‐Yue, et al.
Publicado: (2022)